Security Snapshot

Ocugen, Inc. - Common Stock, par value $0.01 per share (OCGN) Institutional Ownership

CUSIP: 67577C105

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

110

Shares (Excl. Options)

60,919,390

Price

$1.35

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
OCGN on Nasdaq
Shares outstanding
328,357,385
Price per share
$1.87
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
60,919,390
Total reported value
$82,268,116
% of total 13F portfolios
0%
Share change
+15,177,883
Value change
+$19,033,879
Number of holders
110
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • OCGN - Ocugen, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 67577C105.
  • 110 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 110 to 46 between Q4 2025 and Q1 2026.
  • Reported value moved from $82,268,116 to $46,160,959.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 110 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 67577C105?
CUSIP 67577C105 identifies OCGN - Ocugen, Inc. - Common Stock, par value $0.01 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Ocugen, Inc. - Common Stock, par value $0.01 per share (OCGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 6% $26,800,000 20,000,000 JANUS HENDERSON GROUP PLC 28 Nov 2025
MILLENNIUM MANAGEMENT LLC 5.2% $30,904,997 17,074,584 Millennium Management LLC 09 Apr 2026
STATE STREET CORP 2% $4,282,259 5,866,108 STATE STREET CORPORATION 31 Dec 2024
BlackRock, Inc. 1.9% $5,357,737 5,522,302 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 110 institutional investors reported holding 60,919,390 shares of Ocugen, Inc. - Common Stock, par value $0.01 per share (OCGN). This represents 19% of the company’s total 328,357,385 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ocugen, Inc. - Common Stock, par value $0.01 per share (OCGN) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 5% 16,475,562 +8.2% 0% $22,242,009
MILLENNIUM MANAGEMENT LLC 1.6% 5,396,417 +30% 0.01% $7,285,163
UBS Group AG 1.5% 4,849,353 +373% 0% $6,546,627
BlackRock, Inc. 1.4% 4,556,544 +12% 0% $6,151,334
STATE STREET CORP 1.2% 3,978,738 +194% 0% $5,371,296
GEODE CAPITAL MANAGEMENT, LLC 1.2% 3,819,242 +3.9% 0% $5,158,632
MARSHALL WACE, LLP 0.77% 2,530,956 0% $3,416,791
GOLDMAN SACHS GROUP INC 0.7% 2,302,475 +2256% 0% $3,108,341
RENAISSANCE TECHNOLOGIES LLC 0.52% 1,700,400 +486% 0% $2,295,540
JANE STREET GROUP, LLC 0.52% 1,692,134 +93% 0% $2,284,381
CITADEL ADVISORS LLC 0.42% 1,385,953 -12% 0% $1,871,037
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.35% 1,150,460 +31% 0% $1,553,121
Hennion & Walsh Asset Management, Inc. 0.31% 1,005,981 0.05% $1,358,074
Rinkey Investments 0.3% 991,186 -11% 0.34% $1,338,101
Corient Private Wealth LLC 0.27% 900,000 0% 0% $1,215,000
GSA CAPITAL PARTNERS LLP 0.27% 885,118 -15% 0.1% $1,195,000
TWO SIGMA INVESTMENTS, LP 0.21% 678,547 +828% 0% $916,038
NORTHERN TRUST CORP 0.2% 666,237 +12% 0% $899,420
MORGAN STANLEY 0.14% 463,454 +60% 0% $625,663
Point72 Asset Management, L.P. 0.13% 426,293 0% $575,496
XTX Topco Ltd 0.11% 352,127 -23% 0.01% $475,371
OMERS ADMINISTRATION Corp 0.1% 331,300 0% $447,255
TWO SIGMA ADVISERS, LP 0.08% 267,500 0% $361,125
Procyon Advisors, LLC 0.07% 224,100 +6.2% 0.02% $302,535
Squarepoint Ops LLC 0.07% 218,392 +408% 0% $294,829

Institutional Holders of Ocugen, Inc. - Common Stock, par value $0.01 per share (OCGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 25,517,151 $46,160,959 +$4,274,611 $1.81 46
2025 Q4 60,919,390 $82,268,116 +$19,033,879 $1.35 110
2025 Q3 45,903,840 $74,795,914 -$7,601,850 $1.63 97
2025 Q2 51,645,911 $50,101,384 -$22,654,418 $0.97 104
2025 Q1 76,709,568 $54,174,527 +$3,405,595 $0.71 109
2024 Q4 71,666,918 $57,693,526 -$7,365,472 $0.80 112
2024 Q3 79,686,856 $79,054,833 +$11,232,456 $0.99 113
2024 Q2 67,325,448 $104,346,062 +$52,885,517 $1.55 97
2024 Q1 32,871,605 $53,909,488 +$13,559,492 $1.64 77
2023 Q4 26,248,891 $15,093,755 -$3,813,227 $0.58 66
2023 Q3 33,005,604 $13,200,976 -$7,057,643 $0.40 75
2023 Q2 48,731,355 $26,463,195 -$8,334,853 $0.54 93
2023 Q1 62,382,048 $53,214,283 -$25,855,873 $0.85 101
2022 Q4 90,118,981 $117,143,860 +$10,155,984 $1.30 112
2022 Q3 82,377,342 $146,636,679 -$6,742,299 $1.78 111
2022 Q2 85,069,761 $193,110,453 -$1,620,460 $2.27 111
2022 Q1 84,444,251 $278,985,226 +$65,771,926 $3.30 115
2021 Q4 63,969,896 $291,083,536 +$33,898,019 $4.55 108
2021 Q3 55,200,934 $396,342,241 -$11,518,955 $7.18 107
2021 Q2 56,738,114 $455,612,284 +$259,167,423 $8.03 120
2021 Q1 24,638,677 $167,293,331 +$71,984,958 $6.79 72
2020 Q4 14,494,446 $26,522,000 +$1,538,085 $1.83 33
2020 Q3 13,808,280 $4,280,000 +$3,568,100 $0.31 12
2020 Q2 2,543,651 $561,000 -$32,802 $0.22 15
2020 Q1 2,241,789 $631,000 +$152,000 $0.28 10
2019 Q4 467,435 $244,000 -$1,509,661 $0.71 5
2019 Q3 639,820 $1,843,000 +$1,843,000 $2.88 7
2019 Q2 1,722 $14,000 $8.13 1
2019 Q1 1,722 $14,000 $8.13 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .